GHS Cancer Institute — Greenville, South Carolina

GHS Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

GHS Cancer Institute has participated in 9 clinical trials.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Pancreatic Ductal.

Sponsors: Pfizer, Sumitomo Pharma America, Inc., Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GHS Cancer Institute?

GHS Cancer Institute has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GHS Cancer Institute conducted?

GHS Cancer Institute has 9 clinical trials on record. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Pancreatic Ductal.

Is GHS Cancer Institute accredited by Crixeo Health?

Yes — GHS Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about GHS Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.